|
|
|
|
|
by peteretep
2728 days ago
|
|
> The only problem where I don’t yet see a clear path forward yet is how to develop more efficient ways to recruit patients for clinical trials. Without a simple and reliable diagnostic for Alzheimer’s, it’s hard to find eligible people early enough in the disease’s progression who can participate in trials. There’s an interesting use case for Facebook’s Machine Learning algorithms |
|